AAAAAA
Results:
1-7
|
Results: 7
Authors:
Diener, HC
Ringelstein, EB
von Kummer, R
Langohr, HD
Bewermeyer, H
Landgraf, H
Hennerici, M
Welzel, D
Grave, M
Brom, J
Weidinger, G
Citation: Hc. Diener et al., Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the TOPAS trial, STROKE, 32(1), 2001, pp. 22-29
Authors:
Spath, M
Welzel, D
Farber, L
Citation: M. Spath et al., Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results, SC J RHEUM, 29, 2000, pp. 72-77
Authors:
Muller, W
Pongratz, D
Barlin, E
Eich, W
Farber, L
Haus, U
Lautenschlager, J
Mense, S
Neeck, G
Offenbacher, M
Spath, M
Stratz, T
Tolk, J
Welzel, D
Wiech, K
Wohlgemuth, M
Citation: W. Muller et al., The challenge of fibromyalgia: new approaches, SC J RHEUM, 29, 2000, pp. 86-86
Authors:
Shafi, S
Welzel, D
Weidinger, G
Brown, J
Born, GVR
Citation: S. Shafi et al., Effect of reserpine treatment on low-density lipoproteins in arterial walland internal organs of rats, J CARDIO PH, 35(5), 2000, pp. 686-692
Authors:
Shafi, S
Stepanova, IP
Fitzsimmons, C
Bowyer, DE
Welzel, D
Born, GVR
Citation: S. Shafi et al., Effects of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits invivo, ATHEROSCLER, 149(2), 2000, pp. 267-275
Authors:
Beguin, S
Welzel, D
Al Dieri, R
Hemker, HC
Citation: S. Beguin et al., Conjectures and refutations on the mode of action of heparins - The limited importance of anti-factor Xa activity as a pharmaceutical mechanism and ayardstick for therapy, HAEMOSTASIS, 29(2-3), 1999, pp. 170-178
Authors:
Riegger, G
Abletshauser, C
Ludwig, M
Schwandt, P
Widimsky, J
Weidinger, G
Welzel, D
Citation: G. Riegger et al., The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment, ATHEROSCLER, 144(1), 1999, pp. 263-270
Risultati:
1-7
|